Skip to content

Clinical trials

Expanded access Metabolic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Expanded access Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing2
No longer available2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akcea Therapeutics1
Alnylam Pharmaceuticals1
Ionis Pharmaceuticals, Inc.1
Joanne Kurtzberg, MD1
Joyce Fox1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases5
Genetic Diseases, Inborn3
Metabolism, Inborn Errors3
Dyslipidemias2
Hyperlipidemias2
Hyperlipoproteinemia Type I2
Hyperlipoproteinemias2
Lipid Metabolism Disorders2
Lipid Metabolism, Inborn Errors2
Adrenoleukodystrophy1

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.